Literature DB >> 22562614

Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.

Janne Raula1, Jukka Seppälä, Jari Malm, Maarit Karppinen, Esko I Kauppinen.   

Abstract

L-Leucine formed different crystalline coatings on salbutamol sulphate aerosol particles depending on the saturation conditions of L-leucine. The work emphasizes a careful characterization of powders where structural compartments such as crystal size and particle coating may affect the performance of drug when administered. The sublimation of L-leucine from the aerosol particles took place 90°C lower temperature than the bulk L-leucine which was attributed to result from the sublimation of L-leucine from nano-sized crystalline domains. The dissolution slowed down and initial dissolution rate decreased with increasing L-leucine content. Decreasing crystalline domains to nano-scale improve heat and mass transfer which was observed as the lowered decomposition temperature of the drug salbutamol sulphate and the sublimation temperature of surface material L-leucine as well as the altered dissolution characteristics of the drug. The structure of the coated drug particles was studied by means of thermal analysis techniques (DSC and TG), and the dissolution of salbutamol sulphate was studied as an on-line measurement in a diffusion cell.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562614      PMCID: PMC3364384          DOI: 10.1208/s12249-012-9789-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Use of solid corrugated particles to enhance powder aerosol performance.

Authors:  N Y Chew; H K Chan
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Size-dependent melting of silica-encapsulated gold nanoparticles.

Authors:  Kimberly Dick; T Dhanasekaran; Zhenyuan Zhang; Dan Meisel
Journal:  J Am Chem Soc       Date:  2002-03-13       Impact factor: 15.419

3.  Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.

Authors:  Peng Liu; Xinyu Rong; Johanna Laru; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Timo Laaksonen; Leena Peltonen
Journal:  Int J Pharm       Date:  2011-03-31       Impact factor: 5.875

Review 4.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

5.  Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability.

Authors:  G H Ward; R K Schultz
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

6.  Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.

Authors:  Timo Laaksonen; Peng Liu; Antti Rahikkala; Leena Peltonen; Esko I Kauppinen; Jouni Hirvonen; Kristiina Järvinen; Janne Raula
Journal:  Pharm Res       Date:  2011-05-04       Impact factor: 4.200

7.  A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.

Authors:  Janne Raula; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2007-10-20       Impact factor: 4.200

8.  Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.

Authors:  Janne Raula; Anna Lähde; Esko I Kauppinen
Journal:  Int J Pharm       Date:  2008-08-22       Impact factor: 5.875

9.  Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.

Authors:  Janne Raula; Frank Thielmann; Jarno Kansikas; Sami Hietala; Minna Annala; Jukka Seppälä; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2008-06-27       Impact factor: 4.200

10.  The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids.

Authors:  B C Hancock; G Zografi
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.